Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents.

PURPOSE To identify the benefits in image contrast enhancement using gold nanoparticles (AuNPs) compared to conventional iodinated contrast media. MATERIALS AND METHODS Gold nanoparticles and iodinated contrast media were evaluated for contrast enhancement at various X-ray tube potentials in an imaging phantom. Iopromide and AuNP suspension were equalized according to molar concentration of radiopaque element (0.5077 Mol/L). Contrast-to-noise ratio is used to quantify contrast enhancement. Both projectional radiographic (40-80 kVp) and computed tomography (CT) (80-140 kVp) imaging modalities were examined. RESULTS AND CONCLUSIONS Findings indicate 89% improvement in CNR at low energies near the mammographic range (40 kVp). However, as expected no significant difference in enhancement was observed at potentials commonly used for angiography (around 80 kVp) probably due to the k-edge influence for iodine. At the highest energies typically available in computed tomography, significant improvement in contrast enhancement using gold nanoparticles is obtained, 114% greater CNR than that produced by iodine at 140 kVp. Experimental findings for 70-120 kVp spectra correlate well with the theoretical calculations based on linear attenuation coefficients. Superior attenuation of gold nanoparticles at low and high kVp potentials support their further (pre)clinical evaluation.

[1]  Kwon-Ha Yoon,et al.  Colloidal Gold Nanoparticles as a Blood-Pool Contrast Agent for X-ray Computed Tomography in Mice , 2007, Investigative radiology.

[2]  M. Kalra,et al.  Adverse reactions to intravenous iodinated contrast media: an update. , 2006, Current problems in diagnostic radiology.

[3]  J. Foreman,et al.  The incidence of contrast medium induced acute tubular necrosis following arteriography. , 1981, Radiology.

[4]  C E Ravin,et al.  Digital chest radiography with photostimulable storage phosphors: signal-to-noise ratio as a function of kilovoltage with matched exposure risk. , 1993, Radiology.

[5]  Jan Grimm,et al.  An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.

[6]  J. West,et al.  Immunotargeted nanoshells for integrated cancer imaging and therapy. , 2005, Nano letters.

[7]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[8]  Sangjin Park,et al.  Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .

[9]  M Geso,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.

[10]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[11]  H. Thomsen,et al.  Prevention of generalized reactions to contrast media: a consensus report and guidelines , 2001, European Radiology.

[12]  H. Thomsen,et al.  Adverse reactions to iodinated contrast media , 2001, European Radiology.

[13]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[14]  Tao Xu,et al.  Gold-Based Nanoparticles for Breast Cancer Diagnosis and Treatment , 2007, 2007 IEEE International Symposium on Circuits and Systems.

[15]  Jack Baniel,et al.  Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications. , 2007, Biomaterials.

[16]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[17]  Sang Hyun Cho,et al.  Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study , 2005, Physics in medicine and biology.

[18]  S. Bushong,et al.  Radiologic science for technologists: physics, biology, and protection. [Textbook] , 1980 .